Literature DB >> 23742035

Hypertension risk: exercise is medicine* for most but not all.

Jeremy P Loenneke1, Christopher A Fahs, Takashi Abe, Lindy M Rossow, Hayao Ozaki, Thomas J Pujol, Michael G Bemben.   

Abstract

Hypertension is a risk factor for heart disease, and chronic exercise is recognized as a method for reducing resting blood pressure. Recent studies report that while exercise may benefit the majority of the population, the blood pressure adaptation is not always uniform; some individuals have an adverse blood pressure response to chronic aerobic exercise programmes. The purpose of this study was to examine the individual changes in resting blood pressure in response to exercise training regimens aimed at increasing muscle mass and strength. We have also included exercise (resistance and aerobic) in combination with blood flow restriction (BFR). Of 74 individuals, 11% had an increased risk, 16% had a decreased risk and 73% had no change in risk classification following exercise. The statistical analysis found that the group that decreased risk with exercise tended to have higher baseline levels of blood pressure. However, there were little baseline differences between the group that increased risk or the group that had no change in risk, suggesting that starting values may not necessarily determine who will see a beneficial response. In conclusion, the blood pressure adaptation to resistance training and exercise with BFR is not homogeneous with some participants increasing, decreasing or staying in the same risk category following an exercise intervention. These are important findings as they would not have been noted or discussed when looking only at the group means. Future research may identify molecular predictors so that individuals at risk for adverse events can be identified prior to exercise.
© 2013 Scandinavian Society of Clinical Physiology and Nuclear Medicine. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  blood flow restriction; blood pressure; genetics; resistance training; strength

Mesh:

Year:  2013        PMID: 23742035     DOI: 10.1111/cpf.12059

Source DB:  PubMed          Journal:  Clin Physiol Funct Imaging        ISSN: 1475-0961            Impact factor:   2.273


  5 in total

Review 1.  Blood flow restriction training and the exercise pressor reflex: a call for concern.

Authors:  Marty D Spranger; Abhinav C Krishnan; Phillip D Levy; Donal S O'Leary; Scott A Smith
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-04       Impact factor: 4.733

2.  Understanding the individual responsiveness to resistance training periodization.

Authors:  Jonato Prestes; Dahan da Cunha Nascimento; Ramires Alsamir Tibana; Tatiane Gomes Teixeira; Denis Cesar Leite Vieira; Vitor Tajra; Darlan Lopes de Farias; Alessandro Oliveira Silva; Silvana Schwerz Funghetto; Vinicius Carolino de Souza; James Wilfred Navalta
Journal:  Age (Dordr)       Date:  2015-05-14

3.  Best (but oft-forgotten) practices: identifying and accounting for regression to the mean in nutrition and obesity research.

Authors:  Diana M Thomas; Nicholas Clark; Dusty Turner; Cynthia Siu; Tanya M Halliday; Bridget A Hannon; Chanaka N Kahathuduwa; Cynthia M Kroeger; Roger Zoh; David B Allison
Journal:  Am J Clin Nutr       Date:  2020-02-01       Impact factor: 7.045

4.  Blood pressure response to resistance training in hypertensive and normotensive older women.

Authors:  Dahan da Cunha Nascimento; Cristiane Rocha da Silva; Renato Valduga; Bruno Saraiva; Ivo Vieira de Sousa Neto; Amilton Vieira; Silvana Schwerz Funghetto; Alessandro Oliveira Silva; Samuel da Cunha Oliveira; Guilherme Borges Pereira; Jeffrey M Willardson; Jonato Prestes
Journal:  Clin Interv Aging       Date:  2018-04-09       Impact factor: 4.458

5.  Strengthening the Brain-Is Resistance Training with Blood Flow Restriction an Effective Strategy for Cognitive Improvement?

Authors:  Alexander Törpel; Fabian Herold; Dennis Hamacher; Notger G Müller; Lutz Schega
Journal:  J Clin Med       Date:  2018-10-09       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.